Handbook of Prescriptive Treatments for Adults

  • Michel Hersen
  • Robert T. Ammerman

Table of contents

  1. Front Matter
    Pages i-xxiii
  2. Introduction

    1. Front Matter
      Pages 1-1
    2. Ron Acierno, Michel Hersen, Robert T. Ammerman
      Pages 3-27
  3. Specific Disorders

    1. Front Matter
      Pages 29-29
    2. Benoit H. Mulsant, Jules Rosen
      Pages 31-51
    3. Kimberly S. Walitzer, Gerard J. Connors
      Pages 53-71
    4. Stewart A. Anderson, Petronilla Vaulx-Smith, Matcheri S. Keshavan
      Pages 73-94
    5. Lynn P. Rehm, James P. LePage, Susanne Bailey
      Pages 95-117
    6. Robert A. Philibert, George Winokur
      Pages 119-134
    7. Michelle G. Craske, Sachin V. Waikar
      Pages 135-155
    8. Richard P. Mattick, Gavin Andrews
      Pages 157-177
    9. F. Dudley McGlynn
      Pages 179-196
    10. Conor Duggan
      Pages 197-216
    11. Gary Alan-Hue Christenson, Thomas Brooke Mackenzie
      Pages 217-235
    12. Terence M. Keane, Lisa M. Fisher, Karen E. Krinsley, Barbara L. Niles
      Pages 237-260
    13. T. D. Borkovec, Lizabeth Roemer
      Pages 261-281
    14. Pamela E. Parker, Charles V. Ford
      Pages 283-295
    15. Philip M. Coons
      Pages 297-315
    16. Nathaniel McConaghy
      Pages 317-346
    17. Michael P. Carey, Larry J. Lantinga, Dennis J. Krauss
      Pages 347-367
    18. Brant W. Riedel, Kenneth L. Lichstein
      Pages 369-392
  4. Special Issues

    1. Front Matter
      Pages 421-421
    2. Donald A. Williamson, Shannon B. Sebastian
      Pages 423-442
    3. Robert D. Kerns
      Pages 443-461
    4. Grant T. Harris, Marnie E. Rice
      Pages 463-486
    5. Diane R. Follingstad, Heather Breiter
      Pages 487-505
  5. Back Matter
    Pages 507-512

About this book


This book could not have been conceptualized or published 20 years ago. Indeed, it is doubtful that we could have organized the material for this handbook 10 years ago. Over the last 20 years, however, the painstaking efforts of many clinical researchers working with a variety of resistive psychopathologies have resulted in specific psychotherapies and pharmacotherapies that are effective with a significant propor­ tion of patients, at least for some of the disorders. Much clinical research remains to be carried out in the forthcoming decades. But now that we are nearing the 21st century, at least some statement about efficacy can be made. In 1967, Gordon Paul succinctly stated that the ultimate goal of treatment outcome research is to determine "What treatment, by whom, is most effective for this individual with that specific problem, and under which set of circumstances" (p. 111). At that time, empirical evaluations of psychosocial and pharmacologic treatments were few and far between. Methodological strategies for determining treatment effectiveness were also in the formative stage, as exemplified by introduc­ tion of control groups that received inactive interventions (i. e. , placebo) and the relatively recent practice of comparing two or more treatments in addition to placebo. In the almost three decades since Paul's oft-quoted dictum, both the quantity and the quality of treatment outcome research with adults have increased dramati­ cally.


Depression Management bipolar disorder dementia diagnosis

Editors and affiliations

  • Michel Hersen
    • 1
  • Robert T. Ammerman
    • 2
  1. 1.Center for Psychological StudiesNova Southeastern UniversityFort LauderdaleUSA
  2. 2.Western Pennsylvania School for Blind ChildrenPittsburghUSA

Bibliographic information